Risk factors for persistent pleural effusions after the extracardiac Fontan procedure

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 6, 2004, Pages 1664-1669

  Gupta, Anuja ^a,c   Daggett, Casey ^a   Behera, Sarina ^b   Ferraro, Michaelann ^c   Wells, Winfield ^a   Starnes, Vaughn ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; AGE; ARTICLE; BODY WEIGHT; CARDIOPULMONARY BYPASS; CHILD; DRUG USE; FEMALE; FONTAN PROCEDURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; OPERATION DURATION; OUTCOMES RESEARCH; OXYGEN SATURATION; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUBE; UNITED STATES;

EID: 2642578410     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.09.011     Document Type: Article

References (32)

1. de Leval MR. The Fontan circulation: what have we learned? What to expect? Pediatr Cardiol. 1998;19:316-2.
2. Geggel RL. Update on the modified Fontan procedure. Curr Opin Cardiol. 1997;12:51-62.
3. Petrossian E, Reddy VM, McElhinney DB, Akkersdijk GP, Moore P, Parry AJ, et al. Early results of the extracardiac conduit Fontan operation. J Thorac Cardiovasc Surg. 1999;117(4):688-96.
4. Azakie A, McCrindle BW, Arsdell GV, Benson LN, Coles J, Hamilton R, et al. Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution: impact on outcomes. J Thorac Cardiovasc Surg. 2001;122:1219-28.
5. Tokunaga S, Kado H, Imoto Y, Masuda M, Shiokawa Y, Fukae K, et al. Total cavopulmonary connection with an extracardiac conduit: experience with 100 patients. Ann Thorac Surg. 2002;73:76-80.
6. Van Haesdonck JM, Mertens L, Sizaire R, Montas G, Purnode B, Daenen W, et al. Comparison by computerized numeric modeling of energy losses in different Fontan connections. Circulation. 1995;92:322-6.
7. de Leval MR, Dubini G, Migliavacca F, Jalali H, Camporini G, Redington A, et al. Use of computational fluid dynamics in the design of surgical procedures: application to the study of competitive flows in cavopulmonary connections. J Thorac Cardiovasc Surg. 1996;111:502-13.
8. Gentles TL, Mayer JE, Gauvreau K, Newburger JW, Lock JE, Kupferschmid JP, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. 1997;114:376-91.
9. Bradley SM, McCall MM, Sistino JJ, Radtke WK. Aortopulmonary collateral flow in the Fontan patient: does it matter? Ann Thorac Surg. 2001;72:408-15.
10. Triedman JK, Bridges ND, Mayer JE, Lock JE. Prevalence and risk factors for aortopulmonary collateral vessels after Fontan and bidirectional Glenn procedures. J Am Coll Cardiol. 1993;22:207-15.
11. McElhinney DB, Reddy VM, Tworetzky W, Petrossian E, Hanley FL, Moore P. Incidence and implications of systemic to pulmonary collaterals after bi-directional cavopulmonary anastomosis. Ann Thorac Surg. 2000;69:1222-8.
12. Lamberti JJ, Mainwaring RD, Spicer RL, Uzark KC, Moore WJ. Factors influencing perioperative morbidity during palliation of the univentricular heart. Ann Thorac Surg. 1995;60:550-3.
13. Spicer RL, Uzark KC, Moore JW, Mainwaring RD, Lamberti JJ, Aortopulmonary collateral vessels and prolonged pleural effusions after modified Fontan procedures. Am Heart J. 1996;131:1164-8.
14. Merrigan BA, Winter DC, O'Sullivan GC. Chylothorax. Br J Surg. 1997;84:15-20.
15. Fedderly RT, Whitstone BN, Frisbee SJ, Tweddell JS, Litwin SB. Factors related to pleural effusions after the Fontan procedure in the era of fenestration. Circulation. 2001;104(suppl 1):148-51.
16. Gaynor JW, Bridges ND, Cohen MI, Mahle WT, Decampli WM, Steven JM, et al. Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor? J Thorac Cardiovasc Surg. 2002;123:237-45.
17. Tam VK, Miller BE, Murphy K. Modified Fontan without use of cardiopulmonary bypass. Ann Thorac Surg. 1999;68:1698-703.
18. Koutlas TC, Gaynor JW, Nicolson SC, Steven JM, Wernovsky G, Spray TL. Modified ultrafiltration reduces postoperative morbidity after cavopulmonary connection. Ann Thorac Surg. 1997;64:37-42.
19. Thompson LD, McElhinney DB, Culbertson CB, Hardy CE, Brook MM, Reddy VM, et al. Perioperative administration of angiotensin converting enzyme inhibitors decreases the severity and duration of pleural effusions following bi-directional cavopulmonary anastomosis. Cardiol Young. 2001;11:195-200.
20. Heragu N, Mahony L. Is captopril useful in decreasing pleural drainage in children after modified Fontan operation? Am J Cardiol. 1999;84:1109-12.
21. Mainwaring RD, Lamberti JJ, Moore JW, Billman GF, Nelson JC. Comparison of the hormonal response after bidirectional Glenn and Fontan procedures. Ann Thorac Surg. 1994;57:59-64.
22. Julsrud PR, Weigel TJ, Van Son JA, Edwards WD, Mair DD, Driscoll D, et al. Influence of ventricular morphology on outcome after the Fontan procedure. Am J Cardiol. 2000;86:319-23.
23. Kaulitz R, Ziemer G, Luhmer I, Paul T, Kallfelz HC. Total cavopulmonary anastomosis in patients less than three years of age. Ann Thorac Surg. 1995;60(suppl 6):S563-7.
24. Mayer JE, Bridges ND, Lock JE, Hanley F, Jonas RA, Castaneda AR. Factors associated with marked reduction in mortality for Fontan operations in patients with single ventricle. J Thorac Cardiovasc Surg. 1992;103:444-52.
25. Knott-Craig CJ, Danielson GK, Schaff HV, Puga FJ, Weaver AL, Driscoll DD. The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg. 1995;109:1237-43.
26. Hsu DT, Quaegebeur JM, Ing FF, Selber ET, Lamour JM, Gersony WM. Outcomes after the single-stage, nonfenestrated Fontan procedure. Circulation. 1997;96(suppl II):II335-40.
27. Bridges ND, Mayer JE, Lock JE, Jonas RA, Hanley FL, Keane JF, et al. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation. 1992;86:1762-9.
28. Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C. Fenestration improves clinical outcome of the Fontan procedure: a prospective randomized study. Circulation. 2002;105:207-12.
29. Stamm C, Friehs I, Duebener LF, Zurakowski D, Mayer JE Jr, Jonas R, et al. Improving results of the modified Fontan in patients with heterotaxy syndrome. Ann Thorac Surg. 2002;74:1967-77.
30. Bridges ND. Fenestration of the Fontan baffle: benefits and complications. Semin Thorac Cardiovasc Surg. 1998;1:9-14.
31. Mainwaring RD, Lamberti JJ, Carter TL Jr, Moore JW, Nelson JC. Renin, angiotensin II, and the development of effusions following bidirectional Glenn and Fontan procedures. J Card Surg. 1995;10:111-8.
32. Stewart JM, Gewitz MH, Clark BJ, Seligman KP, Romano A, Zeballos GA, et al. The role of vasopressin and atrial natriuretic factor in postoperative fluid retention after the Fontan procedure. J Thorac Cardiovasc Surg. 1991;102:821-9.